GANX
Gain Therapeutics Inc
1.80$
-5.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -0.13 | -0.22 | -0.27 | -1.22 | -1.24 | -1.45 | -0.82 | -0.56 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | |
| – | 0.00 | 0.01 | 0.08 | 0.13 | 0.25 | 0.10 | 0.05 | |
| -0.01 | -0.01 | 0.00 | 0.18 | 0.11 | – | – | – | |
| 0.05 | 0.04 | 0.02 | -0.03 | 0.13 | 0.03 | -0.05 | -0.03 | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | -0.01 | -1.24 | 0.79 | 0.22 | – | |
| 0.17 | 0.09 | 0.06 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | |
| 0.17 | 0.21 | 0.88 | 4.11 | -0.01 | 0.97 | 0.57 | 0.86 | |
| 0.04 | -0.01 | 0.61 | 2.89 | -2.49 | 0.34 | -0.06 | 0.32 | |
| -0.13 | -0.22 | -0.27 | -1.23 | -1.25 | -1.45 | -0.83 | -0.56 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.